ROVALPITUZUMAB TESIRINE

Investigational

Approval Year

Substance Class	Protein
Protein Type	MONOCLONAL ANTIBODY CONJUGATE
Protein Sub Type	IGG1
Sequence Origin	HUMANIZED MOUSE
Sequence Type	COMPLETE
Record UNII	P256HB60FF
Record Status	`Validated (UNII)`
Record Version

Show entries

Name

Type

Language

ROVALPITUZUMAB TESIRINE

Official Name

English

rovalpituzumab tesirine [INN]

Common Name

English

SC-002 [WHO-DD]

Code

English

SC16LD6.5-ADC

Code

English

SC0002

Code

English

Showing 1 to 5 of 10 entries

Previous1 2Next

Show entries

Classification Tree

Code System

Code

Designated/Withdrawn

FDA ORPHAN DRUG

500315

Positive

EU-Orphan Drug

EU/3/16/1667

Showing 1 to 2 of 2 entries

Previous1Next

Show entries

Code System

Code

Type

Description

USAN

DE-143

PRIMARY

CAS

1613313-09-9

PRIMARY

WIKIPEDIA

Rovalpituzumab tesirine

PRIMARY

DRUG BANK

DB13017

PRIMARY

INN

10141

PRIMARY

Showing 1 to 5 of 8 entries

Previous1 2Next

Subunit 0

Subunit 1

Subunit 2

Subunit 3

Show entries

From	To
1_22	1_96
1_145	1_201
1_262	1_322
1_368	1_426
2_22	2_96

Showing 1 to 5 of 16 entries

Previous1 2 3 4Next

Glycosylation Type

MAMMALIAN

Show entries

Glycosylation Link Type	Site
N	1_298
N	2_298

Showing 1 to 2 of 2 entries

Previous1Next

Show entries

Related Record

Type

Details


					Y776670LBR

.DELTA.-LIKE PROTEIN 3

TARGET->CONJUGATED TOXIN

Amount:

Showing 1 to 1 of 1 entries

Previous1Next

Show entries

Related Record

Type

Details


					P256HB60FF

ROVALPITUZUMAB TESIRINE

ACTIVE MOIETY

Amount:

Showing 1 to 1 of 1 entries

Previous1Next

Show entries

Name	Property Type	Amount	Referenced Substance	Defining	Parameters	References
MOL_WEIGHT:NUMBER(CALCULATED)	CHEMICAL	ESTIMATED 145000 Da (average)
Molecular Formula	CHEMICAL	ESTIMATED C6416H9880N1698O2030S46

Showing 1 to 2 of 2 entries

Previous1Next